Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
1A46 Injection for Non-Hodgkin's Lymphoma and Acute Lymphoblastic Leukemia
Recruiting1 awardPhase 1 & 2
Pittsburgh, Pennsylvania
This trial tests a new treatment called 1A46 for adults with advanced blood cancers that haven't responded to other treatments. The treatment works by targeting proteins on cancer cells, helping the immune system destroy them.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service